Pharmacological activities of Curcumin: An update
Research Journal of Pharmacy and Technology
; 15(6):2809-2813, 2022.
Article
in English
| ProQuest Central | ID: covidwho-1975911
ABSTRACT
In the past few years, multiple drugs have been produced from traditional raw materials and recent pandemic disease COVID-19 once again research on this matter is being conducted to determine potential therapeutic purposes of different Ayurvedic Indian medicines and herbs. One such medicinal herb is Curcuma longa. Curcumin is strong antioxidant, anti-inflammatory, antispasmodic, antiangiogenic, anti-carcinogenic, as shown by multiple in vitro and in vivo studies. The action of the growth factor receptors is inhibited by curcumin. The anti-inflammatory effect of curcumin is obtained on the cytokines, proteolytic enzymes, eicosanoids, and lipid mediators. The superoxide radicals, nitric oxide and hydrogen peroxide, are sifted by curcumin, while lipid peroxidation is inhibited. Such properties of the compound thus form the foundation for its various therapeutic and pharmacological effects could also hold antiviral properties including COVID-19. The aim of this research is to summarize the updated pharmacological activities of curcumin.
Pharmacy And Pharmacology; Growth factors; Lipid peroxidation; Gene expression; Neutrophils; Collagen; Nanoparticles; Wound healing; Liver; Disease; Cytokines; Medical research; Inflammation; Antioxidants; Nitric oxide; Colorectal cancer; Lipids; Coronaviruses; Enzymes; Kinases; Cell cycle; Angiogenesis; Proteins; COVID-19
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Language:
English
Journal:
Research Journal of Pharmacy and Technology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS